Pages that link to "Q33518851"
Jump to navigation
Jump to search
The following pages link to Fluorescent substrates useful as high-throughput screening tools for ADAM9. (Q33518851):
Displaying 14 items.
- A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding (Q21132301) (← links)
- ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A. (Q33676656) (← links)
- Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates. (Q34395100) (← links)
- FRET-based and other fluorescent proteinase probes. (Q35086168) (← links)
- Glycosylation of a disintegrin and metalloprotease 17 affects its activity and inhibition (Q35101344) (← links)
- ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein (Q35562470) (← links)
- Potential of fluorescent metalloproteinase substrates for cancer detection (Q35597564) (← links)
- Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates (Q37312014) (← links)
- Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities (Q38431347) (← links)
- Maintenance of neural progenitor cell stemness in 3D hydrogels requires matrix remodelling (Q45072265) (← links)
- Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates (Q47132181) (← links)
- Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration (Q47590431) (← links)
- Considerations on inhibition approaches for proinflammatory functions of ADAM proteases. (Q50495797) (← links)
- Neisseria Heparin Binding Antigen is targeted by the human alternative pathway C3-convertase. (Q52631109) (← links)